Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Patients will be followed up for max 18 months. Information on the Adverse Events and potential misuse or abuse of Xyrem ® will be collected.
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Measure | Description | Time Frame |
|---|---|---|
| Evaluation of risk for development adverse events, withdrawal syndrome and potential for dependence, abuse, overdose and misuse of Xyrem®. Obtaining information about adherence to Xyrem® prescribing information regarding indication and dosage. | 12 months |
Not provided
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Patients being treated with Xyrem®.
Not provided
| Name | Affiliation | Role |
|---|---|---|
| UCB Cares | +1 877 822 9493 (UCB) | Study Director |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| 9 | Graz | Austria | ||||
| 5 |
| PubMed Identifier | Type | Citation | Retractions |
|---|---|---|---|
| 29986085 | Derived | Mayer G, Plazzi G, Iranzo A, Ortega-Albas J, Quinnell T, Pesch H, Serralheiro P, Schlit AF, Wuiame D, Bentz JWG. Long-term compliance, safety, and tolerability of sodium oxybate treatment in patients with narcolepsy type 1: a postauthorization, noninterventional surveillance study. Sleep. 2018 Sep 1;41(9). doi: 10.1093/sleep/zsy128. |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Innsbruck |
| Austria |
| 12 | Antwerp | Belgium |
| 28 | Bruges | Belgium |
| 13 | Brussels | Belgium |
| 34 | Ghent | Belgium |
| 35 | Leuven | Belgium |
| 10 | Liège | Belgium |
| 16 | Prague | Czechia |
| 24 | Berlin | Germany |
| 25 | Berlin | Germany |
| 22 | Bremen | Germany |
| 19 | Hofheim/Taunus | Germany |
| 42 | Katzenelnbogen | Germany |
| 23 | Münster | Germany |
| 20 | Regensburg | Germany |
| 1 | Schwalmstadt | Germany |
| 31 | Ulm | Germany |
| 21 | Westerstede | Germany |
| 4 | Dublin | Ireland |
| 18 | Bologna | Italy |
| 40 | Barakaldo | Spain |
| 11 | Barcelona | Spain |
| 7 | Barcelona | Spain |
| 17 | Castellon | Spain |
| 36 | Donostia / San Sebastian | Spain |
| 32 | Granada | Spain |
| 15 | Madrid | Spain |
| 29 | Madrid | Spain |
| 39 | Palma de Mallorca | Spain |
| 14 | Seville | Spain |
| 37 | Seville | Spain |
| 38 | Vigo | Spain |
| 30 | Vitoria-Gasteiz | Spain |
| 43 | Vitoria-Gasteiz | Spain |
| 41 | Barmelweid | Switzerland |
| 33 | Bern | Switzerland |
| 6 | Zurich | Switzerland |
| 2 | Cambridge | United Kingdom |
| 26 | Essex | United Kingdom |
| 27 | Leicester | United Kingdom |
| ID | Term |
|---|---|
| D009290 | Narcolepsy |
| D002385 | Cataplexy |
| ID | Term |
|---|---|
| D006970 | Disorders of Excessive Somnolence |
| D020919 | Sleep Disorders, Intrinsic |
| D020920 | Dyssomnias |
| D012893 | Sleep Wake Disorders |
| D009422 | Nervous System Diseases |
| D001523 | Mental Disorders |
Not provided
Not provided